Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural ...

RTX Corporation (NYSE:RTX) announced the signing of a Memorandum of Understanding (MoU) with Tawazun Council and Emirates ...

Eli Lilly says a new starting dose regimen for its Alzheimer's disease therapy Kisunla reduces the risk of side effects that have stood in the way of approvals and reimbursement decisions for ...

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest pharma market. The National Medical ...

Jim Cramer says the Fed action is great news for high-growth tech stocks, which should be among the first sectors to recover.